Application no. and date | 16154717.9 (espacenet) (Federated) (European Patent Register), 20121113 | Patent/reg. no. and date | DK/EP 3056187, 20180822 | Publication date | 20160817 | Priority no. and date | IT MI20112066, 20111114 | EP pub. no. and date |
EP 3056187 20160817 | Effective date | | Applicant/owner | Altergon S.a., Via Dogana Vecchia 2
6900 Lugano, CH | Applicant ref. no. | P235887DKEP01 | Inventor | BELLORINI, Lorenzo, c/o ALTERGON S.A. Via Dogana Vecchia, 2
6900 Lugano, CH, BERNAREGGI, Alberto, c/o ALTERGON S.A. Via Dogana Vecchia, 2
6900 Lugano, CH, PIZZUTTI, Marco, c/o ALTERGON S.A. Via Dogana Vecchia, 2
6900 Lugano, CH | Representative | Zacco Denmark A/S, Arne Jacobsens Allé 15, 2300 København S | Opponent | | IPC Class | A61J 1/00 (2023.01) , A61J 7/00 (2006.01) , A61K 31/198 (2006.01) , A61K 47/10 (2017.01) , A61K 9/08 (2006.01) | Title | FARMACEUTISK ENKELTDOSISPRÆPARAT AF THYROIDEAHORMONER T3 OG/ELLER T4 | Int. application no. | | Int. publication no. | | Related patent (certificate) | | Status | Ændret DK/EP patent | Pædiatrisk forlængelse | - | Udløbsdato for pædiatrisk forlængelse | - |
|